The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

COVID-19

Filter Newest Oldest Showing 21-40 of 65 results
Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Maternal Stress and Neonatal Nutrition during the COVID-19 Era

Alara Altıntaş and others

COVID-19 has been the main focus of the world since the beginning of 2020. The virus has infected over 180 million people and caused about 6 million deaths worldwide up to February of 2022. With its rapid spread, the new coronavirus posed enormous economic, environmental, and social challenges together with health threats to the entire (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

The Effect of the Pandemic on Antifungal Use: What Has Changed?

Vildan Avkan-Oğuz and others

Before coronavirus disease 2019 (COVID-19), antimicrobial stewardship (AMS) programs were essential for managing multidrug-resistant Gram-negative bacterial infections. In contrast, antifungal stewardship (AFS) programs were uncommon as a component of AMS. During the COVID-19 pandemic, both AMS and AFS programs have lost (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Antibiotic Use among Patients Hospitalized with COVID-19 and Treated in Three Different Clinics

Oğuz Evlice and others

The clinical spectrum of COVID-19 varies, ranging from asymptomatic infection to critical illness. The most commonly used tool for the classification of disease severity is the National Institute of Health (NIH) severity scale, which has four categories: mild, moderate, severe, and critical. Patients with moderate and severe clinical courses are followed up in wards, while those with (...) Read More

Case Report / VOLUME 4, ISSUE 3, SEPTEMBER 2022

A Case of Acute Parotitis Associated with COVID-19

Sinan Çetin and Tayfun Ayeser

Coronavirus disease 2019 (COVID-19) emerged in Wuhan, China, at the end of 2019 with pneumonia cases and spread worldwide in a short time, leading to a pandemic. The cause of the disease was severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The World Health Organization (WHO) declared a pandemic (...) Read More

Case Report / VOLUME 4, ISSUE 3, SEPTEMBER 2022

An Unusual Cause of Acute Isolated Hepatitis in a Cancer Patient Post-COVID Pneumonia: HSV-2

Türkkan Öztürk-Kaygusuz and others

Herpes simplex virus (HSV) is a double-stranded DNA alphaherpesvirus. HSV-1 is a common human pathogen infecting more than 60% of the world’s population, and HSV-2 infects about 11% of the population. HSV rarely causes visceral organ infections. However, some of these disseminated infections are life-threatening. Hepatitis due to HSV is a rare (...) Read More

Case Report / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Subacute and Recurrent Transient Perivascular Inflammation of the Carotid Artery (TIPIC syndrome) and Supraclavicular Lymphadenopathy Associated with Ipsilateral Intramuscular m-RNA COVID-19 Vaccine

Sıla Ulus and others

Transient perivascular inflammation of the carotid artery (TIPIC) syndrome is a rare disease. Recently, characteristic imaging findings were classified. The most common appearance is the existence of focal eccentric thickening of the carotid wall and abnormal soft tissue surrounding the carotid artery, especially near the bifurcation and usually without any (...) Read More

Commentary / VOLUME 4, ISSUE 2, JUNE 2022

Management of COVID-19 Cases in Kosova

Salih Ahmeti and others

International collaborative consultations are significantly beneficial in combatting pandemics, although such opportunities were quite limited during the COVID-19 pandemic. We had the chance to convene with the experts to share experiences and review the practices in Kosova. Two days of expert consultation hybrid meeting […] Read More

Brief Report / VOLUME 4, ISSUE 2, JUNE 2022

SARS-CoV-2 IgG Antibody Levels After Inactivated Vaccine (CoronaVac) among Elderly

Harika Öykü Dinç and others

Despite the decrease in incidence after having widespread vaccination programs, the COVID-19 pandemic continues to cause high morbidity and mortality in the world in its second year. Especially elderly people (over 65 years old), people with underlying health conditions, and healthcare workers (HCWs) are still at high risk for COVID-19 disease. Since […] Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

HIV and SARS‐Cov‐2 Co-Infection: A Local Perspective

Heval Can Bilek and Aydın Deveci

In early December 2019, interstitial pneumonia of unknown origin emerged in Wuhan, the capital of China’s Hubei province. The pathogen was identified as a novel beta coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the disease caused by SARS-CoV-2 was later named (...) Read More

Original Article / VOLUME 4, ISSUE 1, MARCH 2022

ANTIBACDUS-PAN: Antibacterial Utilization among Adult Patients Before and During COVID-19 Pandemic within 12-Months Period: A Tertiary Hospital Pharmacoepidemiology Study

Ege Anıl Uçar and others

Rational use of medicines (RUM) has been a concern worldwide for half a century, and is of great importance, given that almost half of all prescribed drugs are irrational. The irrational use of drugs can be disastrous and may cause adverse events, creating a (...) Read More

Original Article / VOLUME 4, ISSUE 1, MARCH 2022

Predictors of Severity and Mortality in COVID-19: A Retrospective Study from Batman, Turkey

Fethiye Akgül and others

At the beginning of the 21st century, three deadly epidemics related to coronaviruses have struck the world. Severe acute respiratory syndrome (SARS) originated in 2002, Middle East respiratory syndrome (MERS) in 2012, and finally COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019. COVID-19 (...) Read More

Original Article / VOLUME 4, ISSUE 1, MARCH 2022

COVID-19 in Elderly Patients: Risk Factors for Disease Severity

Pınar Korkmaz and others

At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China. It spread rapidly, resulting in a pandemic throughout the world. In February 2020, the World Health Organization (WHO) named the disease COVID-19. Studies reported that COVID-19 mostly progressed with asymptomatic (...) Read More

Commentary / VOLUME 3, ISSUE 3, DECEMBER 2021

Virtual Learning Opportunity During COVID-19 Pandemic: Comparison of Virtual (2021) and Face to Face (2019) Conferences of Turkish Society of Clinical Microbiology and Infectious Diseases

Önder Ergönül and others

About the last 10-year if not older, electronic learning as a training method in infectious diseases (ID) and clinical microbiology (CM) was defined as an area to be improved. In a survey published in 2017 by the European Society of Clinical Microbiology (...) Read More